Understanding and Targeting Apoptotic Pathways in Ovarian Cancer

Understanding and Targeting Apoptotic Pathways in Ovarian Cancer

Ovarian cancer cells evade the immune system as well as chemotherapeutic and/or biologic treatments through inherent or acquired mechanisms of survival and drug resistance. Depending on the cell type and the stimuli, this threshold can range from external forces such as blunt trauma to programmed pr...

Full description

Bibliographic Details
Main Authors:	Linah F. Al-Alem, Andrew T. Baker, Unnati M. Pandya, Eric L. Eisenhauer, Bo R. Rueda
Format:	Article
Language:	English
Published:	MDPI AG 2019-10-01
Series:	Cancers
Subjects:	apoptosis ovarian cancer chemoresistance glycosylation mirna clinical trials
Online Access:	https://www.mdpi.com/2072-6694/11/11/1631

Similar Items

Equol induces apoptosis in chemoresistant ovarian cancer cells via external pathway
by: Xue-Mei Gong, et al.
Published: (2015-12-01)

Galectins and Ovarian Cancer
by: Chisa Shimada, et al.
Published: (2020-05-01)

CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
by: Xiaojie Feng, et al.
Published: (2019-06-01)

Drug resistance in ovarian cancer: from mechanism to clinical trial
by: Ling Wang, et al.
Published: (2024-03-01)

HOXB9 Overexpression Confers Chemoresistance to Ovarian Cancer Cells by Inducing ERCC-1, MRP-2, and XIAP
by: Dong Hoon Suh, et al.
Published: (2023-01-01)

Optimized Transcriptional Signature for Evaluation of MEK/ERK Pathway Baseline Activity and Long-Term Modulations in Ovarian Cancer
by: Mikhail S. Chesnokov, et al.
Published: (2022-11-01)

Apoptosis-related gene expression can predict the response of ovarian cancer cell lines to treatment with recombinant human TRAIL alone or combined with cisplatin
by: Letícia da Conceição Braga, et al.
Published: (2020-03-01)

Leveraging Genomics, Transcriptomics, and Epigenomics to Understand the Biology and Chemoresistance of Ovarian Cancer
by: Sandra Muñoz-Galván, et al.
Published: (2021-08-01)

Mechanisms Involved in Chemoresistance in Ovarian Cancer
by: Kar-San Ling, et al.
Published: (2005-09-01)

Aryl Hydrocarbon Receptor Promotes Cell Growth, Stemness Like Characteristics, and Metastasis in Human Ovarian Cancer via Activation of PI3K/Akt, β-Catenin, and Epithelial to Mesenchymal Transition Pathways
by: Lubna Therachiyil, et al.
Published: (2022-06-01)

Glutathione Transferase P1: Potential Therapeutic Target in Ovarian Cancer
by: Petar Simic, et al.
Published: (2022-11-01)

Effect of PLGA Nanoparticle-Mediated Delivery of miRNA 503 on The Apoptosis of Ovarian Endometriosis Cells
by: Shahla Chaichian, et al.
Published: (2022-11-01)

The effects of REG4 expression on chemoresistance of ovarian cancer
by: Li-Wei Xiang, et al.
Published: (2022-10-01)

The role of DNA methylation in ovarian cancer chemoresistance: A narrative review
by: Kaiyang Song, et al.
Published: (2023-05-01)

Copper exposure induces ovarian granulosa cell apoptosis by activating the caspase-dependent apoptosis signaling pathway and corresponding changes in microRNA patterns
by: Yiqin Chen, et al.
Published: (2023-10-01)

Interaction of Adenosine, Modified Using Carborane Clusters, with Ovarian Cancer Cells: A New Anticancer Approach against Chemoresistance
by: Katarzyna Bednarska-Szczepaniak, et al.
Published: (2021-07-01)

Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer
by: Li-yuan Feng, et al.
Published: (2020-03-01)

Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells
by: Dauren Alimbetov, et al.
Published: (2018-06-01)

Ovarian Cancer: Treatment and Resistance to Pharmacotherapy
by: David Lukanović, et al.
Published: (2022-05-01)

Purinergic signalling pathway: therapeutic target in ovarian cancer
by: Nisha Chandran, et al.
Published: (2020-06-01)

Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
by: Zaman Mohd Saif, et al.
Published: (2012-12-01)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
by: Lynn Roy, et al.
Published: (2018-07-01)

Prediction of Chemoresistance—How Preclinical Data Could Help to Modify Therapeutic Strategy in High-Grade Serous Ovarian Cancer
by: Jacek Wilczyński, et al.
Published: (2023-12-01)

Flavonoids Restore Platinum Drug Sensitivity to Ovarian Carcinoma Cells in a Phospho-ERK1/2-Dependent Fashion
by: Yifat Koren Carmi, et al.
Published: (2020-09-01)

Double Insurance for OC: miRNA-Mediated Platinum Resistance and Immune Escape
by: Xueqin Zou, et al.
Published: (2021-04-01)

PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway
by: Fang Zheng, et al.
Published: (2023-11-01)

Dysregulation of Cholesterol Homeostasis in Ovarian Cancer
by: Zahraa Qusairy, et al.
Published: (2023-09-01)

Ovarian cancer: Current status and strategies for improving therapeutic outcomes
by: Ashwin Chandra, et al.
Published: (2019-11-01)

HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process
by: Sijia Ma, et al.
Published: (2024-02-01)

CASC11 Overexpression Predicts Poor Prognosis and Regulates Cell Proliferation and Apoptosis in Ovarian Carcinoma
by: Cui Y, et al.
Published: (2020-01-01)

Eclalbasaponin II induces autophagic and apoptotic cell death in human ovarian cancer cells
by: Yoon Jin Cho, et al.
Published: (2016-09-01)

Regulatory Role of the Adipose Microenvironment on Ovarian Cancer Progression
by: Hussein Chehade, et al.
Published: (2022-05-01)

Inhibition of Notch signaling in combination with paclitaxel reduces platinum-resistant ovarian tumor growth
by: Jolijn W Groeneweg, et al.
Published: (2014-07-01)

The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer
by: Marek Nowak, et al.
Published: (2020-05-01)

Chimeric Antigen Receptor Design and Efficacy in Ovarian Cancer Treatment
by: Katarzyna M. Terlikowska, et al.
Published: (2021-03-01)

Tertiary Prevention of Ovarian Cancer After PARP Inhibitor Therapy
by: ZANG Rongyu
Published: (2023-02-01)

Advances in the Relationship between MicroRNA and Cisplatin Resistance  of Lung Cancer
by: Fang ZHANG, et al.
Published: (2014-03-01)

Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
by: Concetta Altamura, et al.
Published: (2021-02-01)

The SP1-12LOX axis promotes chemoresistance and metastasis of ovarian cancer
by: Qi Zhang, et al.
Published: (2020-05-01)

Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer
by: Nicole E. James, et al.
Published: (2018-04-01)